[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-349555-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-349555-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","lnc122-rna-prevents-liver-tumorigenesis-in-myc-driven-liver-cancer","lnc122 RNA prevents liver tumorigenesis in MYC-driven liver cancer","","The study investigates long non-coding RNA lnc122 as more than a precursor of microRNA-122 (miR-122) in liver disease. Using CRISPRi inhibition of lnc122 in hepatoma cells and mouse livers with or without mature miR-122, it evaluates roles in hepatic homeostasis and a MYC-driven tumor model. Results show lnc122 promotes MYC protein degradation by stabilizing the UBR5-MYC ubiquitin ligase complex. Loss of lnc122 worsens MYC-driven liver tumorigenesis and decreases lnc122 levels in human hepatocellular carcinoma.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/lnc122-rna-prevents-liver-tumorigenesis-in-myc-driven-liver-cancer/349555/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/lnc122-rna-prevents-liver-tumorigenesis-in-myc-driven-liver-cancer/349555.png","ImageObject",300,407,{"name":42,"@type":43},"RuangKosong","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main focus of the study about lnc122?","Question",{"text":63,"@type":64},"The study examines whether lnc122 has a separate biological function beyond being a precursor to miR-122, particularly in preventing MYC-driven liver tumorigenesis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did the researchers test lnc122’s function?",{"text":68,"@type":64},"They used CRISPRi to inhibit lnc122 in hepatoma cells and mouse livers, with and without mature miR-122, and combined approaches including RNA-seq, gene set enrichment analysis, RNA pulldown-mass spectrometry, and a CRISPRa/CRISPRi liver tumor model.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism does the study identify for MYC regulation?",{"text":72,"@type":64},"lnc122 stabilizes the UBR5-MYC E3 ubiquitin ligase complex, promoting MYC protein degradation in a way distinct from miR-122’s antiproliferative role.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},349555,1790497056,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090883219,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Research article  \nlnc122 RNA prevents liver tumorigenesis in MYC-driven  \nliver cancer  \nAuthors  \nHagoon Jang, Feijie Zhang, Bo Kyoung Suh,   , Calvin J. Stephens, Kerriann M. Casey, Mark A. Kay  \nCorrespondence  \n[markay@stanford.edu](markay@stanford.edu) (M.A. Kay).  \nGraphical abstract  \nHighlights:  \n• lnc122 RNA is the precursor to miR-122 and has separate molecular functions.  \n• lnc122 RNA enhances the UBR5-MYC interaction to promote MYC ubiquitination and degradation.  \n• Reduction of lnc122 RNA even in the presence of miR-122 enhances MYC-driven hepatic tumors in mice.  \n• lnc122 and miRNA-122 RNA levels are reduced in human hepatocellular carcinomas compared to paired normal liver tissue.  \nImpact and implications:  \nThe study demonstrates that lnc122 RNA not only is a precursor for miR-122, but also functions in forming a ubiquitination complex via UBR5, and responsible for limiting the halflife of MYC protein. Loss of lnc122 RNA expression promotes liver cancer perhaps categorizing it as tumor suppressor gene. Further studies to develop agents to enhance the activity of this complex may offer a new therapeutic approach to treat hepatocellular carcinoma.  \n[https://doi.org/10.1016/j.jhepr.2026.101916](https://doi.org/10.1016/j.jhepr.2026.101916)  \n© 2026 The Author(s) . Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL) . This is an open access article under the CC BYNC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/)). JHEP Reports, 2026, 8, 1–16  \nResearch article  \nlnc122 RNA prevents liver tumorigenesis in MYC-driven  \nliver cancer  \nHagoon Jang1 , 2 , Feijie Zhang1 , 2 , Bo Kyoung Suh1 , 2 , Anh Le1 , 2 , Calvin J. Stephens1 , 2 , Kerriann M. Casey3 , Mark A. Kay1 , 2 , *  \nJHEP Reports 2026. vol. 8 | 1–16  \nBackground & Aims: Extensive research has shown that the microRNA-122 (miR-122) plays an important role in liver homeostasis, and its dysregulation has been implicated in various liver pathologies such as liver cancer and non-alcoholic fatty liver disease. The primary transcript for miR-122, long non-coding RNA 122 (lnc122) has traditionally only been considered an intermediate product for mature miR-122 .  \nMethods: We used CRISPRi to inhibit lnc122 RNA expression in hepatoma cells and mouse livers with and without expression of mature miR-122 RNA to determine if a lnc122 RNA has a separate function. These models were used in combination of RNA-seq, Gene Set Enrichment Analysis, RNA pulldown-mass spectrometry, and a CRSIRPi/CRISPRa mediated liver tumor model to establish the specific role of lnc122 in hepatic homeostasis.  \nResults: We demonstrate that lnc122 RNA has a distinct tumor suppressive role that is separate from the antiproliferative function of miR-122 . Specifically, lnc122 RNA promotes MYC protein degradation by stabilizing the MYC-UBR5 E3 ubiquitin ligase protein complex. Unlike other E3 ubiquitin ligases for MYC, UBR5 is co-amplified with MYC in >40% of human cancers because of their close location on the human genome and lnc122 is indispensable for efficient MYC degradation by UBR5 . Paired patient liver and tumor samples showed decreased concentrations of lnc122 RNA in tumors. Furthermore, reducing the lnc122 RNA transcripts in mouse liver exacerbated MYC-driven liver tumorigenesis. Although lnc122 expression is restricted to the liver, exogenous expression of lnc122 in non-hepatic transformed cells also destabilized MYC protein.  \nConclusions: Our findings indicate that lnc122 RNA has a synergistic role with miR-122 in the surveillance and prevention of liver tumorigenesis and may represent a new target for treating MYC-driven human cancers.  \n© 2026 The Author(s) . Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL) . This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/by-nc-nd/4.0/](http:","cbCaijbZnKMBQwMh","https://ap.wps.com/l/cbCaijbZnKMBQwMh","pdf",7652571,17,"English","# Background & Aims\n# Methods\n# Results\n# Conclusions\n# Introduction","[{\"question\":\"What is the main focus of the study about lnc122?\",\"answer\":\"The study examines whether lnc122 has a separate biological function beyond being a precursor to miR-122, particularly in preventing MYC-driven liver tumorigenesis.\"},{\"question\":\"How did the researchers test lnc122’s function?\",\"answer\":\"They used CRISPRi to inhibit lnc122 in hepatoma cells and mouse livers, with and without mature miR-122, and combined approaches including RNA-seq, gene set enrichment analysis, RNA pulldown-mass spectrometry, and a CRISPRa/CRISPRi liver tumor model.\"},{\"question\":\"What mechanism does the study identify for MYC regulation?\",\"answer\":\"lnc122 stabilizes the UBR5-MYC E3 ubiquitin ligase complex, promoting MYC protein degradation in a way distinct from miR-122’s antiproliferative role.\"}]","lnc122 RNA prevents liver tumorigenesis in MYC-driven liver cancer | PDF",1790084304,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/afa4699ac62f773b37a9d768e86e7e25.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/47b73018f163e128afc405ac0ae6ca5e.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/854520599d9426c11dff2bc828c6d680.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49442cdef96950327eea30fc58253e15.webp",980,1306]